Citigroup’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8
| Closed | -$13 | – | 6249 |
|
|
2026
Q1 | $13 | Buy |
+8
| New | +$19 | ﹤0.01% | 5721 |
|
|
2025
Q1 | – | Sell |
-75
| Closed | -$811 | – | 5968 |
|
|
2024
Q4 | $811 | Buy |
+75
| New | +$968 | ﹤0.01% | 5609 |
|
|
2021
Q1 | – | Sell |
-26
| Closed | -$11K | – | 7363 |
|
|
2020
Q4 | $11K | Hold |
26
| – | – | ﹤0.01% | 6929 |
|
|
2020
Q3 | $8K | Hold |
26
| – | – | ﹤0.01% | 6779 |
|
|
2020
Q2 | $9K | Sell |
26
-12
| -32% | -$4.79K | ﹤0.01% | 7105 |
|
|
2020
Q1 | $39K | Buy |
38
+28
| +280% | +$40.8K | ﹤0.01% | 6204 |
|
|
2019
Q4 | $13K | Buy |
10
+8
| +400% | +$11.3K | ﹤0.01% | 7118 |
|
|
2019
Q3 | $4K | Sell |
2
-11
| -85% | -$17.8K | ﹤0.01% | 7404 |
|
|
2019
Q2 | $30K | Sell |
13
-18
| -58% | -$53K | ﹤0.01% | 6871 |
|
|
2019
Q1 | $91K | Buy |
31
+30
| +3,000% | +$66.3K | ﹤0.01% | 5842 |
|
|
2018
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 7600 |
|
|
2018
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 7686 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 7552 |
|
|
2018
Q1 | $1K | Sell |
1
-1
| -50% | -$3K | ﹤0.01% | 7474 |
|
|
2017
Q4 | $8K | Hold |
2
| – | – | ﹤0.01% | 7118 |
|
|
2017
Q3 | $8K | Sell |
2
-1
| -33% | -$4.28K | ﹤0.01% | 6758 |
|
|
2017
Q2 | $13K | Sell |
3
-28
| -90% | -$118K | ﹤0.01% | 6446 |
|
|
2017
Q1 | $169K | Sell |
31
-10
| -24% | -$46.6K | ﹤0.01% | 4802 |
|
|
2016
Q4 | $186K | Buy |
41
+11
| +37% | +$137K | ﹤0.01% | 5337 |
|
|
2016
Q3 | $623K | Buy |
30
+9
| +43% | +$163K | ﹤0.01% | 3693 |
|
|
2016
Q2 | $323K | Sell |
21
-3
| -13% | -$68.5K | ﹤0.01% | 4065 |
|
|
2016
Q1 | $679K | Buy |
24
+12
| +100% | +$254K | ﹤0.01% | 3792 |
|
|
2015
Q4 | $346K | Sell |
12
-5
| -29% | -$165K | ﹤0.01% | 4240 |
|
|
2015
Q3 | $411K | Buy |
17
+14
| +467% | +$943K | ﹤0.01% | 3933 |
|
|
2015
Q2 | $269K | Buy |
3
+2
| +200% | +$183K | ﹤0.01% | 4207 |
|
|
2015
Q1 | $109K | Hold |
1
| – | – | ﹤0.01% | 4970 |
|
|
2014
Q4 | $135K | Buy |
+1
| New | +$73.2K | ﹤0.01% | 5006 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6329 |
|
|
2014
Q2 | – | Sell |
-10
| Closed | -$236K | – | 6392 |
|
|
2014
Q1 | $259K | Buy |
10
+9
| +900% | +$255K | ﹤0.01% | 4090 |
|
|
2013
Q4 | $26K | Buy |
+1
| New | +$27.4K | ﹤0.01% | 6071 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6980 |
|
Other funds holding TPST
SM
VVM
Citigroup's TPST Position: Q2 2026 in Review
Citigroup sold out of Tempest Therapeutics (TPST) in Q2 2026, closing a stake of 8 shares — an estimated $13 sold.
Citigroup first reported a position in TPST in Q4 2013 and held it in 29 quarters. The position peaked at $679K in Q1 2016. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.
- Citigroup reported no remaining Tempest Therapeutics position as of Q2 2026 after selling out during the quarter.
- Citigroup sold 8 Tempest Therapeutics shares in Q2 2026, an estimated $13.
- Citigroup first reported a position in Tempest Therapeutics in Q4 2013 and held it in 29 quarters.
- Citigroup's Tempest Therapeutics position peaked at $679K in Q1 2016.
- 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.